Osteoporosis Fracture Clinical Trial
Official title:
Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area
NCT number | NCT02803190 |
Other study ID # | 201604037RINB |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2016 |
Est. completion date | December 2023 |
Verified date | November 2022 |
Source | National Taiwan University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators' previous studies in 2014 and 2015 have demonstrated that among community-dwelling older adults with high osteoporotic fracture risks. many sarcopenia indices can be improved and bone mineral density (BMD) maintained with different exercise programs. In 2016, the investigators aim to determine the effects of 2 exercise interventions on posture corrections and further improvement of sarcopenic indices
Status | Completed |
Enrollment | 108 |
Est. completion date | December 2023 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 100 Years |
Eligibility | Inclusion Criteria: 1. older than 50 years of age 2. high risk as defined from one of the following criteria: score=1 on one minute osteoporosis risk questionnaire; 10 year predicted fracture risk=20% for major osteoporotic fracture or =3% for hip fracture from FRAX; fall=2 times in pass 1 year 3. having a bone mineral density test within one year period 4. having the capability to understand the study and complete the study interventions 5. willing to participate for the intervention and study follow ups Exclusion Criteria: 1. People younger than 50 years of age 2. Could not communicate because of hearing, visual, or cognitive problems 3. Unable to stand and walk unaided (walking aids are acceptable) |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital | Taiwanese Osteoposis Association, Wang Jhan-Yang Charitable Trust Fund |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Lower extremety extensor power | Lower extremity extensor power is measured by isokinetic resistance equipment by a tranined research assistant with standarized protocol.
We will compare the statistical properties between baseline and after 12 weeks intervention. |
baseline and 12 weeks | |
Secondary | appendicular skeletal muscle index | Measured by bioimpedence analysis machine, before and after intervention. We will compare the statistical properties between baseline and after 12 weeks intervention. | baseline and 12 weeks | |
Secondary | grip strength | Measured by dynamometer, before and after intervention. We will compare the statistical properties of between baseline and after 12 weeks intervention. | baseline and 12 weeks | |
Secondary | walking speed | Measured before and after intervention. Subjects are asked to walk 9 meters. The time between 2 and 7 meter mark are recorded. Walking speed is defined as meter/sec We will compare the statistical properties between baseline and after 12 weeks intervention. | baseline and 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06024148 -
Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
|
||
Completed |
NCT03710889 -
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
|
Phase 3 | |
Recruiting |
NCT05058976 -
Romosozumab Use to Build Skeletal Integrity
|
Phase 4 | |
Completed |
NCT03798444 -
Height Loss, Kyphosis Indicators, Bone Mineral Density and Vertebral Fractures in Chinese Postmenopausal Women
|
||
Completed |
NCT04960033 -
Evaluating Fracture Risk Assessment Tools (FRAX) From Different Regions in Central South Chinese Postmenopausal Women
|
||
Not yet recruiting |
NCT04597931 -
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
|
Phase 4 | |
Completed |
NCT05366621 -
Post-fracture Medication and Mortality
|
||
Completed |
NCT02483286 -
Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area
|
N/A | |
Enrolling by invitation |
NCT03178799 -
Randomized Fracture Liaison Services
|
||
Recruiting |
NCT03451305 -
Postrual Reduction With Pillow in Osteoporotic Vertebral Fracture
|
N/A | |
Recruiting |
NCT03811509 -
Breast Cancer Women on Aromatase Inhibitors Treatment
|
Phase 4 | |
Recruiting |
NCT06379243 -
Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures
|
N/A |